Nuveen LLC Invests $10.13 Million in National Health Investors, Inc. $NHI

Key Points

• Nuveen LLC has acquired 137,092 shares of National Health Investors, Inc. for approximately $10.1 million, representing a 0.29% ownership stake.
• Analysts have upgraded National Health Investors to a consensus rating of "Buy" with a price target of $85.40, including an upgrade to "overweight" by KeyCorp.
• The company recently announced an increase in its quarterly dividend to $0.92 per share, offering a yield of 4.7%, with a dividend payout ratio of 115.02%.

Nuveen LLC bought a new position in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 137,092 shares of the real estate investment trust's stock, valued at approximately $10,126,000. Nuveen LLC owned 0.29% of National Health Investors at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Aigen Investment Management LP purchased a new stake in shares of National Health Investors in the first quarter valued at about $318,000. Entropy Technologies LP purchased a new stake in shares of National Health Investors in the first quarter valued at about $310,000. Invesco Ltd. lifted its holdings in shares of National Health Investors by 1.6% in the first quarter. Invesco Ltd. now owns 127,008 shares of the real estate investment trust's stock valued at $9,381,000 after purchasing an additional 1,983 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in shares of National Health Investors by 4.4% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 31,114 shares of the real estate investment trust's stock valued at $2,298,000 after purchasing an additional 1,319 shares in the last quarter. Finally, Centersquare Investment Management LLC lifted its holdings in shares of National Health Investors by 25.7% in the first quarter. Centersquare Investment Management LLC now owns 495,971 shares of the real estate investment trust's stock valued at $36,632,000 after purchasing an additional 101,538 shares in the last quarter. Hedge funds and other institutional investors own 62.51% of the company's stock.

National Health Investors Trading Down 0.3%

NYSE:NHI traded down $0.21 during trading hours on Thursday, reaching $77.54. 197,952 shares of the company were exchanged, compared to its average volume of 227,890. The company has a debt-to-equity ratio of 0.75, a current ratio of 10.91 and a quick ratio of 10.91. The firm has a market cap of $3.68 billion, a price-to-earnings ratio of 24.77, a PEG ratio of 3.34 and a beta of 0.73. National Health Investors, Inc. has a 52-week low of $65.13 and a 52-week high of $86.13. The stock has a 50 day simple moving average of $72.59 and a 200 day simple moving average of $72.77.

National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share for the quarter, topping analysts' consensus estimates of $1.16 by $0.06. The company had revenue of $70.27 million for the quarter, compared to the consensus estimate of $86.46 million. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. National Health Investors's revenue was up 6.7% on a year-over-year basis. During the same quarter last year, the firm posted $1.18 earnings per share. As a group, analysts predict that National Health Investors, Inc. will post 4.41 EPS for the current year.

National Health Investors Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be paid a dividend of $0.92 per share. This is an increase from National Health Investors's previous quarterly dividend of $0.90. This represents a $3.68 dividend on an annualized basis and a yield of 4.7%. The ex-dividend date of this dividend is Tuesday, September 30th. National Health Investors's payout ratio is 115.02%.

Wall Street Analyst Weigh In

Several brokerages have issued reports on NHI. Wedbush raised shares of National Health Investors to a "strong-buy" rating in a report on Wednesday, July 2nd. Truist Financial upped their price objective on shares of National Health Investors from $77.00 to $81.00 and gave the company a "buy" rating in a research note on Friday, August 15th. KeyCorp raised shares of National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 price objective on the stock in a research note on Thursday, July 10th. Finally, Wells Fargo & Company upped their price objective on shares of National Health Investors from $76.00 to $80.00 and gave the company an "equal weight" rating in a research note on Wednesday. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $84.20.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.